Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Johnson & Johnson (JNJ) NYSE

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 312,045,024
  • Shares Outstanding, K 2,735,880
  • Annual Sales, $ 70,074 M
  • Annual Income, $ 15,409 M
  • 36-Month Beta 0.72
  • Price/Sales 4.34
  • Price/Book 4.29

Price Performance

See More
Period Period Low Period High Performance
1-Month
113.37 +0.69%
on 01/12/17
117.00 -2.44%
on 01/10/17
-1.51 (-1.31%)
since 12/20/16
3-Month
109.32 +4.42%
on 12/07/16
122.50 -6.82%
on 11/09/16
-0.72 (-0.63%)
since 10/20/16
52-Week
94.28 +21.08%
on 01/21/16
126.07 -9.46%
on 07/20/16
+18.40 (+19.22%)
since 01/20/16

Most Recent Stories

More News
What's in Store for Abbott Labs (ABT) This Earnings Season?

Abbott Laboratories (ABT) is scheduled to report fourth-quarter and full year 2016 results before the opening bell on Jan 25.

Q4 Earnings Growth the Highest in 8 Quarters

Q4 Earnings Growth the Highest in 8 Quarters

Q4 Earnings Growth the Highest in 8 Quarters

Q4 Earnings Growth the Highest in 8 Quarters

Ethicon Announces Acquisition of Megadyne Medical Products, Inc.

Ethicon Endo-Surgery, Inc. announced today that it has acquired Megadyne Medical Products, Inc., a privately held medical device company that develops, manufactures and markets electrosurgical tools used...

Abbvie (ABBV) Imbruvica Approved in Lymphoma Indication

AbbVie Inc. (ABBV) announced that the FDA has approved its blood cancer drug, Imbruvica, for the treatment of patients with relapsed/refractory (R/R) marginal zone lymphoma (MZL).

What???s Ahead for Johnson & Johnson (JNJ) in Q4 Earnings?

Johnson & Johnson (JNJ), the bellwether of healthcare companies, is scheduled to report fourth-quarter 2016 and full-year results on Jan 24.

Technical Reports on Drug Makers Stocks -- Pfizer, Merck, AbbVie, and Johnson & Johnson

Today, Stock-Callers.com takes another look at the Drug Manufacturers space to see how current market conditions are influencing the performances of some major players in the industry. Under evaluation...

Research and Markets - Global Multiple Myeloma Drugs Market 2017-2021 with Amgen, Celgene, Johnson & Johnson, Novartis & Takeda Pharmaceuticals Dominating

DUBLIN, Jan 16, 2017 /PRNewswire/ --

Research and Markets - Global Multiple Myeloma Drugs Market 2017-2021 with Amgen, Celgene, Johnson & Johnson, Novartis & Takeda Pharmaceuticals Dominating

Research and Markets has announced the addition of the "Global Multiple Myeloma Drugs Market 2017-2021" report to their offering.

A4L Expands into JLABS @ Toronto

Today, Analytics 4 Life (A4L), a machine intelligence company developing noninvasive, cost-effective medical devices, announced its expansion into JLABS @ Toronto, one of Johnson & Johnson Innovation's...

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin...

See More

Support & Resistance

2nd Resistance Point 115.37
1st Resistance Point 114.76
Last Price 114.15
1st Support Level 113.81
2nd Support Level 113.47

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.